Patients with diabetes with and without sodium-glucose cotransporter-2 inhibitors use with incident cancer risk
Wei‐Syun Hu, Cheng‐Li Lin
Topics & Concepts
MedicineHazard ratioDiabetes mellitusInternal medicineProportional hazards modelConfidence intervalCohortCohort studyIncidence (geometry)CancerEmpagliflozinDapagliflozinLower riskType 2 diabetesOncologyEndocrinologyOpticsPhysicsDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes